CAI Caris Life Sciences, Inc.
CAI Caris Life Sciences, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $18.53 · VWAP $22.69 · +41.1% vs 12m avg buyer
Insiders selling 0 buy / 2 sell · Form 4, 90d $27M sold last open-market sell Brille Brian J
Cluster 2 reporting owners sold $12.4M, Sep 17–23
Coverage
1 watchlist
CAI Price Structure
Loading timeframes…
Peers
Every watchlist CAI belongs to, members best 30-day change first — CAI highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How CAI's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
CAI research tape
35 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.